Immunesensor Therapeutics Inc.

This early-stage study tests a new drug called IMSB301 in people with a rare group of diseases called type 1 interferonopathies, where the immune system is overactive. The main goal is to check if the drug is safe and how it moves through the body. Only 6 participants are being e…